Healthcare AI Leaders Are Rapidly Trying To Outmaneuver Skyrocketing Memory And GPU Costs
Compute power has become one of the most crucial components of the healthcare delivery cycle.
- NVIDIA's H100 GPU prices have tripled since 2023, with healthcare AI providers reporting 40–60% increases in compute spend per model deployment, according to industry surveys.
- Memory bandwidth costs—driven by high-bandwidth memory (HBM) shortages—now account for over 30% of total AI inference expenses in radiology and pathology workloads.
- Startups like Groq and Cerebras are gaining traction with processor-in-memory architectures that reduce reliance on traditional GPUs, claiming up to 70% cost savings for certain healthcare models.
- Mayo Clinic and Mass General Brigham have publicly committed $150 million each to multi-year cloud compute contracts, locking in rates to hedge against future price spikes.
- A report from McKinsey estimates that compute costs could absorb 15–25% of healthcare AI budgets by 2028 if current trends persist, potentially delaying FDA approvals for new clinical AI tools.
"The cost of compute is becoming the biggest barrier to scaling AI in healthcare — we're seeing hospitals pay more for GPUs than for the actual software licenses."
"If we don't solve the memory cost problem, we risk creating a two-tier system where only the wealthiest institutions can deploy cutting-edge diagnostic AI."
Frequently Asked Questions
Demand for large language models and medical imaging AI has surged, outpacing supply of high-bandwidth memory and enterprise GPUs. Shortages of HBM and NVIDIA's H100 have driven prices 3x higher since 2023.
Hospitals are locking in multi-year cloud contracts, investing in custom ASIC chips, and adopting processor-in-memory architectures from startups like Groq and Cerebras that cut costs by up to 70%.
If unchecked, compute costs could absorb 15–25% of AI budgets by 2028, potentially delaying FDA approvals and creating a divide between well-funded institutions and smaller clinics.
Yes, startups like Groq, Cerebras, and Mythic offer alternative architectures. Also, major cloud providers like AWS and Google are developing custom AI chips (Trainium, TPU) tailored for inference.
Long-term, competition, chip improvements, and software optimizations (model compression, pruning) should lower costs. However, near-term shortages and growing AI demand may keep pressure on prices through 2027.
Memory bandwidth is critical for real-time radiology and pathology AI. High costs force trade-offs in image resolution or batch sizes, potentially reducing diagnostic accuracy or throughput.
Topics
Original source
www.forbes.com
Discussion
Join the discussion
Sign in to post a comment or reply.
No comments yet. Be the first to share your thoughts!